Home ›
Trademark Categories ›
Pharmaceuticals ›
2008 ›
EN ›
ENEXPRA
Trademark search for:
ENEXPRA
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2008-03-14 — Application filed
2008-03-19 — Application filed
2008-03-28 — Paper received
2008-04-02 — Assigned to lie
2008-04-03 — Preliminary/voluntary amendment - entered
2008-04-30 — Suspension letter written
2008-04-30 — Notification of letter of suspension e-mailed
2008-04-30 — Assigned to examiner
2008-04-30 — Letter of suspension e-mailed
2008-05-15 — Attorney/dom.rep.revoked and/or appointed
2008-05-15 — Teas revoke/app/change addr of atty/dom rep received
2008-10-30 — Suspension inquiry written
2008-10-30 — Inquiry to suspension e-mailed
2008-10-30 — Notification of inquiry as to suspension e-mailed
2009-04-29 — Teas response to suspension inquiry received
2009-04-29 — Correspondence received in law office
2009-04-30 — Teas/email correspondence entered
2009-05-04 — Final disposition recorded
2009-05-04 — Final disposition recorded
2009-05-04 — Final disposition recorded
2009-05-05 — Examiners amendment -written
2009-05-05 — Approved for pub - principal register
2009-05-05 — Examiners amendment e-mailed
2009-05-05 — Notification of examiners amendment e-mailed
2009-05-05 — Examiner's amendment entered
2009-05-06 — Data modification completed
2009-05-07 — Law office publication review completed
2009-05-20 — Notice of publication
2009-06-09 — Published for opposition
2009-07-09 — Extension of time to oppose received
2009-07-28 — Application abandoned
2009-08-24 — Extension of time to oppose process - terminated
2009-08-24 — Application abandoned
2009-08-24 — Application abandoned
2009-08-24 — Final status recorded
Owner Information
AstraZeneca AB
Sodertalje SE
AstraZeneca AB
Sodertalje SE
Correspondent
Wm. Charles Saunders AstraZeneca Pharmaceuticals LP 1800 Concord Pike OW2 Wilmington, DE 19850-5437
Filing Details
Filing Date:
2008-03-14
Status Date:
2009-08-24
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.